Display Settings:

Format

Send to:

Choose Destination
    Nat Rev Drug Discov. 2006 Dec;5(12):997-1014.

    Mining the Wnt pathway for cancer therapeutics.

    Source

    Hubrecht laboratory, Netherlands Institute for Developmental Biology, Uppsalalaan 8 3584CT, Utrecht, The Netherlands. nbarker@niob.knaw.nl

    Erratum in

    • Nat Rev Drug Discov. 2007 Mar;6(3):249.

    Abstract

    Aberrant activation of the Wnt pathway is implicated in driving the formation of various human cancers, particularly those of the digestive tract. Inhibition of aberrant Wnt pathway activity in cancer cell lines efficiently blocks their growth, highlighting the great potential of therapeutics designed to achieve this in cancer patients. Here we provide an overview of the promise and pitfalls of current drug development strategies striving to inhibit the Wnt pathway and present new opportunities for therapeutic intervention.

    PMID:
    17139285
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk